John E. Schiel
YOU?
Author Swipe
View article: Detecting Features of Protein Structure through their Mediator-Accessible Redox Activities
Detecting Features of Protein Structure through their Mediator-Accessible Redox Activities Open
Protein function relies on sequence, folding, and post-translational modification, and molecular measurements are commonly used to reveal these structural features. Here, we report an alternative approach that represents these molecular fe…
View article: Managing integrated continuous bioprocesses in real time: Deviations in product quality
Managing integrated continuous bioprocesses in real time: Deviations in product quality Open
The N‐mAb case study was produced by the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) to support teaching and learning for both industry and regulators around adoption of advanced manufacturing process tec…
View article: Characterizing Adeno-Associated Virus Capsids with both Denaturing and Intact Analysis Methods
Characterizing Adeno-Associated Virus Capsids with both Denaturing and Intact Analysis Methods Open
Adeno-associated virus (AAV) capsids are among the leading gene delivery platforms used to treat a vast array of human diseases and conditions. AAVs exist in a variety of serotypes due to differences in viral protein (VP) sequences, with d…
View article: Humanized monoclonal antibody IgG1k, NISTmAb RM 8671 summary of 5 year stability verification (5YSV)
Humanized monoclonal antibody IgG1k, NISTmAb RM 8671 summary of 5 year stability verification (5YSV) Open
NISTmAb RM 8671 is an IgG1k monoclonal antibody that has been extensively characterized and released as the first of its kind biopharmaceutical reference material in 2016. This material was intended primarily for use in evaluating the perf…
View article: Biomanufacturing readiness levels [BRL]—A shared vocabulary for biopharmaceutical technology development and commercialization
Biomanufacturing readiness levels [BRL]—A shared vocabulary for biopharmaceutical technology development and commercialization Open
The Manufacturing Readiness Levels (MRLs) developed by the Department of Defense are well‐established tools for describing the maturity of new technologies resulting from government‐sponsored Research and Development programs, from the con…
View article: Bioindustrial manufacturing readiness levels (BioMRLs) as a shared framework for measuring and communicating the maturity of bioproduct manufacturing processes
Bioindustrial manufacturing readiness levels (BioMRLs) as a shared framework for measuring and communicating the maturity of bioproduct manufacturing processes Open
Readiness level (RL) frameworks such as technology readiness levels and manufacturing readiness levels describe the status of a technology/manufacturing process on its journey from initial conception to commercial deployment. More importan…
View article: Attribute Analytics Performance Metrics from the MAM Consortium Interlaboratory Study
Attribute Analytics Performance Metrics from the MAM Consortium Interlaboratory Study Open
The multi-attribute method (MAM) was conceived as a single assay to potentially replace multiple single-attribute assays that have long been used in process development and quality control (QC) for protein therapeutics. MAM is rooted in tr…
View article: Interlaboratory Studies Using the NISTmAb to Advance Biopharmaceutical Structural Analytics
Interlaboratory Studies Using the NISTmAb to Advance Biopharmaceutical Structural Analytics Open
Biopharmaceuticals such as monoclonal antibodies are required to be rigorously characterized using a wide range of analytical methods. Various material properties must be characterized and well controlled to assure that clinically relevant…
View article: A Sensitive and Controlled Data-Independent Acquisition Method for Proteomic Analysis of Cell Therapies
A Sensitive and Controlled Data-Independent Acquisition Method for Proteomic Analysis of Cell Therapies Open
Mass spectrometry (MS)-based proteomic measurements are uniquely poised to impact the development of cell and gene therapies. With the adoption of rigorous instrumental performance qualifications (PQs), large-scale proteomics can move from…
View article: Ligand-Bound Forced Degradation as a Strategy to Generate Functionally Relevant Analytical Challenge Materials for Assessment of CQAs
Ligand-Bound Forced Degradation as a Strategy to Generate Functionally Relevant Analytical Challenge Materials for Assessment of CQAs Open
Therapeutic monoclonal antibodies (mAbs) contain a variety of amino acids that are susceptible to enzymatic, chemical, and physical modifications. These modifications can happen throughout production, purification, formulation, and storage…
View article: Metrological tools for the reference materials and reference instruments of the NIST Material Measurement Laboratory
Metrological tools for the reference materials and reference instruments of the NIST Material Measurement Laboratory Open
The National Institute of Standards and Technology (NIST), formerly the National Bureau of Standards, was established by the U.S. Congress in 1901 and charged with establishing a measurement foundation to facilitate U.S. and international …
View article: New Peak Detection Performance Metrics from the MAM Consortium Interlaboratory Study
New Peak Detection Performance Metrics from the MAM Consortium Interlaboratory Study Open
The Multi-Attribute Method (MAM) Consortium was initially formed as a venue to harmonize best practices, share experiences, and generate innovative methodologies to facilitate widespread integration of the MAM platform, which is an emergin…
View article: Mass Spectrometry Advances and Perspectives for the Characterization of Emerging Adoptive Cell Therapies
Mass Spectrometry Advances and Perspectives for the Characterization of Emerging Adoptive Cell Therapies Open
Adoptive cell therapy is an emerging anti-cancer modality, whereby the patient’s own immune cells are engineered to express T-cell receptor (TCR) or chimeric antigen receptor (CAR). CAR-T cell therapies have advanced the furthest, with rec…
View article: Cyberbiosecurity for Biopharmaceutical Products
Cyberbiosecurity for Biopharmaceutical Products Open
Cyberbiosecurity is an emerging discipline that addresses the unique vulnerabilities and threats that occur at the intersection of cyberspace and biotechnology. Advances in technology and manufacturing are increasing the relevance of cyber…
View article: Antigenicity and Immunogenicity of Differentially Glycosylated Hepatitis C Virus E2 Envelope Proteins Expressed in Mammalian and Insect Cells
Antigenicity and Immunogenicity of Differentially Glycosylated Hepatitis C Virus E2 Envelope Proteins Expressed in Mammalian and Insect Cells Open
The development of a vaccine for hepatitis C virus (HCV) remains a global health challenge. A major challenge for vaccine development is focusing the immune response on conserved regions of the HCV envelope protein, E2, capable of elicitin…
View article: Heterologous recombinant expression of non-originator NISTmAb
Heterologous recombinant expression of non-originator NISTmAb Open
The successful development and regulatory approval of originator and biosimilar therapeutic proteins requires a systems approach to upstream and downstream processing as well as product characterization and quality control. Innovation in p…
View article: The NISTmAb Reference Material 8671 lifecycle management and quality plan
The NISTmAb Reference Material 8671 lifecycle management and quality plan Open
View article: Development of orthogonal NISTmAb size heterogeneity control methods
Development of orthogonal NISTmAb size heterogeneity control methods Open
View article: Qualification of NISTmAb charge heterogeneity control assays
Qualification of NISTmAb charge heterogeneity control assays Open
View article: The NISTmAb Reference Material 8671 value assignment, homogeneity, and stability
The NISTmAb Reference Material 8671 value assignment, homogeneity, and stability Open
The NISTmAb Reference Material (RM) 8671 is intended to be an industry standard monoclonal antibody for pre-competitive harmonization of best practices and designing next generation characterization technologies for identity, quality, and …
View article: Development of an LC-MS/MS peptide mapping protocol for the NISTmAb
Development of an LC-MS/MS peptide mapping protocol for the NISTmAb Open
View article: NIST Spectroscopic Measurement Standards.
NIST Spectroscopic Measurement Standards. Open
Ultraviolet (UV) absorbance measurements provide a rapid and reliable method to determine protein concentrations. the National Institute of standards and technology (NIST) has developed Standard Reference Material (SRM) 2082 as a pa…
View article: Multivariate Analysis of Two-Dimensional <sup>1</sup>H, <sup>13</sup>C Methyl NMR Spectra of Monoclonal Antibody Therapeutics To Facilitate Assessment of Higher Order Structure
Multivariate Analysis of Two-Dimensional <sup>1</sup>H, <sup>13</sup>C Methyl NMR Spectra of Monoclonal Antibody Therapeutics To Facilitate Assessment of Higher Order Structure Open
Two-dimensional (2D) 1H-13C methyl NMR provides a powerful tool to probe the higher order structure (HOS) of monoclonal antibodies (mAbs), since spectra can readily be acquired on intact mAbs at natural isotopic abund…